Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme

被引:16
作者
Wang, YH
Bruenn, JA
Queener, SF
Cody, V
机构
[1] Hauptman Woodward Med Res Inst, Struct Biol Dept, Buffalo, NY 14203 USA
[2] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
关键词
D O I
10.1128/AAC.45.9.2517-2523.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
While assays of many antifolate inhibitors for dihydrofolate reductase (DHFR) have been performed using rat DHFR as a target, neither the sequence nor the structure of rat DHFR is known. Here, we report the isolation of the rat DHFR gene through screening of a rat liver cDNA library. The rat liver DHFR gene has an open reading frame of 561 bp encoding a protein of 187 amino acids. Comparisons of the rat enzyme with those from other species indicate a high level of conservation at the primary sequence level and more so for the amino acid residues comprising the active site of the enzyme. Expression of the rat DHFR gene in bacteria produced a recombinant protein with high enzymatic activity. The recombinant protein also paralleled the human enzyme with respect to the inhibition by most of the antifolates tested with PT652 and PT653 showing a reversal in their patterns. Our results indicated that rat DHFR can be used as a model to study antifolate compounds as potential drug candidates. However, variations between rat and human DHFR enzymes, coupled with unique features in the inhibitors, could lead to the observed differences in enzyme sensitivity and selectivity.
引用
收藏
页码:2517 / 2523
页数:7
相关论文
共 55 条
[1]   ACTIVITY OF ANTIFOLATES AGAINST PNEUMOCYSTIS-CARINII DIHYDROFOLATE-REDUCTASE AND IDENTIFICATION OF A POTENT NEW AGENT [J].
ALLEGRA, CJ ;
KOVACS, JA ;
DRAKE, JC ;
SWAN, JC ;
CHABNER, BA ;
MASUR, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) :926-931
[2]  
BERTINO JR, 1987, NATL CANCER I MONOGR, V5, P87
[3]  
Blakley R L, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P23
[4]  
BLAKLEY RL, 1984, FOLATES PTERIDINES, V1
[5]   STRUCTURE ACTIVITY RELATIONSHIPS OF DIHYDROFOLATE-REDUCTASE INHIBITORS [J].
BLANEY, JM ;
HANSCH, C ;
SILIPO, C ;
VITTORIA, A .
CHEMICAL REVIEWS, 1984, 84 (04) :333-407
[6]   PNEUMOCYSTIS-CARINII DIHYDROFOLATE-REDUCTASE USED TO SCREEN POTENTIAL ANTIPNEUMOCYSTIS DRUGS [J].
BROUGHTON, MC ;
QUEENER, SF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (07) :1348-1355
[7]  
BURCHALL JJ, 1965, MOL PHARMACOL, V1, P126
[8]   STRUCTURE OF PNEUMOCYSTIS-CARINII DIHYDROFOLATE-REDUCTASE TO 1.9-ANGSTROM RESOLUTION [J].
CHAMPNESS, JN ;
ACHARI, A ;
BALLANTINE, SP ;
BRYANT, PK ;
DELVES, CJ ;
STAMMERS, DK .
STRUCTURE, 1994, 2 (10) :915-924
[9]   IDENTIFICATION OF HIGHLY POTENT AND SELECTIVE INHIBITORS OF TOXOPLASMA-GONDII DIHYDROFOLATE-REDUCTASE [J].
CHIO, LC ;
QUEENER, SF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (09) :1914-1923
[10]   Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+ [J].
Cody, V ;
Galitsky, N ;
Rak, D ;
Luft, JR ;
Pangborn, W ;
Queener, SF .
BIOCHEMISTRY, 1999, 38 (14) :4303-4312